Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcription profiling of liver and small intestine from Cyp3a/Mdr1a/1b knock-out mice and wild-type mice


ABSTRACT: comparison Cyp3a/Mdr1a/1b ko mice with wild-type mice (both FVB background)

ORGANISM(S): Mus musculus

SUBMITTER: Robert van Waterschoot 

PROVIDER: E-NCMF-26 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicity.

van Waterschoot Robert A B RA   Lagas Jurjen S JS   Wagenaar Els E   van der Kruijssen Cornelia M M CM   van Herwaarden Antonius E AE   Song Ji-Ying JY   Rooswinkel Rogier W RW   van Tellingen Olaf O   Rosing Hilde H   Beijnen Jos H JH   Schinkel Alfred H AH  

Cancer research 20091117 23


Docetaxel is one of the most widely used anticancer drugs. A major problem with docetaxel treatment, however, is the considerable interpatient variability in docetaxel exposure. Another disadvantage of the drug is that it has a very low oral bioavailability and can therefore only be administered i.v. The drug-metabolizing enzyme cytochrome P450 3A (CYP3A) and the drug transporter P-glycoprotein (P-gp; MDR1) are considered to be major determinants of docetaxel pharmacokinetics. It has been hypoth  ...[more]

Similar Datasets

2007-10-09 | E-NCMF-2 | biostudies-arrayexpress
2009-04-01 | E-NCMF-24 | biostudies-arrayexpress
2008-08-01 | E-NCMF-11 | biostudies-arrayexpress
2010-08-20 | E-NCMF-3 | biostudies-arrayexpress
2013-03-21 | E-MTAB-1448 | biostudies-arrayexpress
2011-02-19 | E-NCMF-37 | biostudies-arrayexpress
2009-02-14 | E-NCMF-18 | biostudies-arrayexpress
2008-02-19 | E-NCMF-8 | biostudies-arrayexpress
2010-01-05 | E-NCMF-28 | biostudies-arrayexpress